Clinical Trials
Phase III study showed Rituxan/MabThera decreased the risk of...
Roche announced positive data from a Phase III study of Rituxan/MabThera (rituximab) in patients with advanced follicular lymphoma who did not have symptoms of disease...
Clinical Trials
QR Pharma receives FDA clearance to conduct clinical trials...
 QR Pharma, Inc., a developer of novel drugs to treat Alzheimer's disease (AD), announced today that the United States Food and Drug Administration (FDA)...
Clinical Trials
Bayer and Regeneron Report Positive Top-Line Results of Two...
Bayer HealthCare and Regeneron Pharmaceuticals, Inc. announced that in two parallel Phase 3 studies in patients with the neovascular form of age-related macular degeneration (wet...
Clinical Trials
Reata and Abbott Announce Positive Phase 2b Study Results...
Abbott Park, Illinois-Reata Pharmaceuticals and Abbott today announced data from a Phase 2b study which suggests that bardoxolone methyl, an investigational treatment for chronic kidney...
Clinical Trials
Novartis discontinues ASA404 clinical trial program and shifts focus...
Novartis announced that the clinical trial program for the investigational cancer treatment ASA404 (vadimezan) will be discontinued and resources will be reallocated to other compounds...
Clinical Trials
Genentech announced the result of Phase II clinical trail...
Genentech, Inc., a member of the Roche Group announced results from a Phase II clinical study of RG7204 (PLX4032), an investigational first-in-class molecule designed to...
Clinical Trials
Sanofi Pasteur’s Dengue Vaccine in Final Stage of Clinical...
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced that its dengue vaccine is in final stage of clinical development. Sanofi Pasteur’s dengue vaccine, the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.